The AHA today expressed support for the Excellence in Mental Health and Addiction Treatment Expansion Act (H.R.1767/S. 824), bipartisan legislation that would renew and expand an innovative demonstration program that expands access to treatment of mental illnesses and substance use disorders through community-based clinics.
 
To increase access to care, Congress, in the Protecting Access to Medicare Act, authorized demonstration programs in up to eight states to improve community behavioral health services through certified community behavioral health clinics – a new comprehensive treatment model that launched in 2017. Statutory authority for the CCBHC program will end in June 2019 unless Congress acts.
 
“Your timely legislation would renew the CCBHC demonstration program in the original eight states (Minnesota, Missouri, Nevada, New Jersey, New York, Oklahoma, Oregon and Pennsylvania) for two years and expand it to 11 additional states, enabling current patients to continue receiving comprehensive care, and increasing the number of individuals with access to vital services,” AHA said.
 
The legislation was introduced in the House by Reps. Doris Matsui, D-Calif., and Markwayne Mullin, R-Okla., and in the Senate by Sens. Roy Blunt, R-Mo., and Debbie Stabenow, D-Mich.

Perspective
Public
May is Mental Health Awareness Month, a time to elevate a conversation that hospitals and health systems live every day. Behavioral health is inseparable from…
Headline
The AHA April 29 urged House and Senate appropriations committee leaders to fund health care programs that have been successful in improving access to care for…
Headline
The AHA submitted a statement for the record to the House Ways and Means Committee for its April 28 hearing with health system CEOs.In the statement, the AHA…
Headline
The Food and Drug Administration today announced it is accelerating regulatory action on a new class of psychedelic-based therapies, following an April 18…
Headline
The Senate April 23 adopted a budget resolution by a 50-48 vote, paving the way for a narrow reconciliation bill focused on immigration enforcement funding.…
Headline
President Trump April 18 signed an executive order to accelerate research into psychedelic drugs for the treatment of serious mental illnesses, calling…